At 6.4% CAGR, the Middle East & Africa Implantable Medical Devices Market is Projected to be Worth US$ 5,342.10 million by 2030, Says Business Market Insights

According to Business Market Insights research, the Middle East & Africa implantable medical devices market was valued at US$ 3,246.72 million in 2022 and is expected to reach US$ 5,342.10 million by 2030, registering a CAGR of 6.4% from 2022 to 2030. Growing areas of application of implantable medical devices and rising cases of spinal cord injury attributed to the Middle East & Africa implantable medical devices market expansion.

3D printing technology has been used in implantable medical devices because of its high precision, complex structure, and high material utilization advantages. The 3D printing technology is used when the shape of the implantable medical devices is complex and often difficult to process. 3D printing technology can produce implantable medical devices with any complex shape without considering processing problems and solve complex implantable medical devices' design and manufacturing problems. Long-term medical solutions for breast implants, implantable cardioverter-defibrillators, pacemakers, and dentures are possible with the help of 3D printing technology. One of the most recent advancements in orthopedic implant technology is 3D printing. With the rapid advancement of technology in the medical field, smart implants embedded with sensors and 3D printing can completely replace traditional implants in use; the ability to create custom implants for individual patients has added benefits during treatment. 3D-printed implants could even reduce the number of surgeries required for a given condition; for example, glaucoma stents 3D printed from a dissolvable polymer could eliminate the follow-up surgery for removing the titanium devices, which are commonly used. Therefore, the growing use of 3D printing technology is expected to propel the growth of the market in the coming years.

On the contrary, post-surgical complications hampers the Middle East & Africa implantable medical devices market.

Based on implant type, the Middle East & Africa implantable medical devices market is bifurcated into active implant & passive implant. The passive implant segment held 55.7% share of Middle East & Africa implantable medical devices market in 2022, amassing US$ 1,808.31 million. It is projected to garner US$ 2,889.56 million by 2030 to expand at 6.0% CAGR during 2022-2030.

Based on product type, the Middle East & Africa implantable medical devices market is bifurcated into diagnostic & treatment. The treatment segment held 81.4% share of Middle East & Africa implantable medical devices market in 2022, amassing US$ 2,643.84 million. It is projected to garner US$ 4,432.51 million by 2030 to expand at 6.7% CAGR during 2022-2030.

Based on material type, the Middle East & Africa implantable medical devices market is segmented into metallic, ceramic, and polymers. The metallic segment held 55.2% share of Middle East & Africa implantable medical devices market in 2022, amassing US$ 1,790.91 million. It is projected to garner US$ 2,948.53 million by 2030 to expand at 6.4% CAGR during 2022-2030.

Based on application, the Middle East & Africa implantable medical devices market is segmented into dental implants, orthopedic implants, cardiovascular implants, breast implants, brain implants, and others. The orthopedic implants segment held 47.7% share of Middle East & Africa implantable medical devices market in 2022, amassing US$ 1,548.57 million. It is projected to garner US$ 2,578.88 million by 2030 to expand at 6.6% CAGR during 2022-2030.

Based on end users, the Middle East & Africa implantable medical devices market is segmented into hospitals, specialty clinics, ASCs, and others. The hospitals segment held 55.2% share of Middle East & Africa implantable medical devices market in 2022, amassing US$ 1790.77 million. It is projected to garner US$ 2953.72 million by 2030 to expand at 6.5% CAGR during 2022-2030.

Based on country, the Middle East & Africa implantable medical devices market has been categorized into the Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 35.9% share of Middle East & Africa implantable medical devices market in 2022. It was assessed at US$ 1,166.14 million in 2022 and is likely to hit US$ 1,975.53 million by 2030, exhibiting a CAGR of 6.8% during 2022-2030.

Key players operating in the Middle East & Africa implantable medical devices market Abbott Laboratories, Boston Scientific Corp, Dentsply Sirona Inc, Johnson & Johnson, Medtronic Plc, Institut Straumann AG, Smith & Nephew Plc, Livanova Plc, and MED-EL Elektromedizin Gerate Gesellschaft mbH, among others.

In Nov-2022, Smith+Nephew announced the introduction of its JOURNEY II ROX Total Knee Solution - a reverse hybrid construct for total knee arthroplasty. This new procedural product solution aims to provide surgeons with the clinical advantage of an advanced bearing material and anatomic design combined with the efficiency and potential long-term tibia fixation of a cementless knee.


Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com